Pharmaceutical stocks in the medical sector
Pharmaceutical stocks in the medical sector, which requires access to relevant information in order to answer the answer, according to years of learning experience, if the answer to the medical sector of the medical stocks, can make you twice as easy, the following share of the medical sector of the medical stocks of the relevant methods of experience for you to refer to learn from.
Medical sector pharmaceutical stocks
Medical sector pharmaceutical stocks are many, the following are some common:
___Pharmaceutical business: Shanghai Pharmaceuticals (601607), China Pharmaceuticals (600560), Guangzhou Pharmaceuticals (600332), China Resources Pharmaceuticals (03908)
__Medical Devices: Yuyue Medical (002223), Lepu Medical (300003), Lanwei Medical (301060), Wanbangde (002006)
__Biological Products: Hualan Bio (002007), Watson Bio (300142), Changchun High-Tech (000661), Zhifei Bio (300122), Kangtai Bio ( 300601)
___Pharmaceutical Manufacturing: Pientzehuang (600436), Yunnan Baiyao (000538)
___Chemical Pharmaceuticals: Tiger Pharmaceuticals (300378), Kelaiyin (002821), Zhaoyanxin Pharmaceuticals (603127), Yakushima Science and Technology (300725), Meikang Bio (300439)
___Medical services: Aier Ophthalmology (300015), Tongze Medical (600655), Meinian Health (002044), Kangtai Biologicals (300601)
The above companies are all listed companies in China's A-share market in the healthcare sector, which are related to pharmaceuticals. It should be noted that investment involves risks, and investors should choose to invest according to their own risk tolerance.
Medical sector leading stocks list
Medical sector leading stocks are:
1.Myriad Medical: leading stocks. Domestic medical equipment leader, medical imaging, in vitro diagnostics, medical diagnosis and treatment of three major areas.
2. OpusCare: ophthalmic medical leader.
3. Tigermed: clinical trial CRO industry leader.
4. UW Genetics: a leader in gene sequencing.
5. Contagious Bio: vaccine leader.
6. Zhifei Bio: vaccine leader.
7. Hualan Bio: leading vaccine and blood products.
8. Health Yuan: innovative drug leader.
9. Nanxin Pharmaceuticals: pharmaceutical leader.
10.Iwu biology: desensitization drug leader.
11.Hysco: innovative drug leader.
12. Qian Zhen Cao Health: leading Chinese medicine.
13. Baiyunshan: pharmaceutical business leader.
14. Xinkaipu: intelligent medical leader.
15. Lepu medical: cardiovascular diagnostic and treatment equipment leader.
16. Yang Pu medical: medical device leader.
17.Baolite: medical device health management leader.
18. Jianfan Bio: blood purification device leader.
19. Kangtai biology: vaccine industry, a new stock.
20.Hualan Vaccine: potential stock in domestic vaccine industry.
The above list is for reference only, if you want to get more information about leading stocks in the medical sector, we recommend you to check more comprehensive official information or consult professionals.
Which are the Chinese medicine stocks in the medical sector
The Chinese medicine stocks in the medical sector are:
1.Antelope Pharmaceuticals: It has strong brand influence and competitiveness in the Chinese medicine industry.
2. Healthy People Group: focusing on the field of great health.
3. Taiji Group: has rich product reserves and diversified product lines, with main products including Huo Xiang Zheng Qi Capsule, Syrup of Urgent Support, Compound Danshen Tablets and Banlangen Granules.
4. Hwasen Pharmaceutical: the company has its own production capacity of Chinese medicine formula granules and chemical pharmaceutical preparations.
5. Jiangzhong Pharmaceutical: It is a Chinese medicine pharmaceutical company with a history of nearly 50 years.
6. Hulu: its main products include pediatric drugs, gynecological drugs, antibiotics and antineoplastic drugs.
7. Longjian: to invest in the construction of Longjian shares Yueqing Traditional Chinese Medicine Hospital (Longhui Traditional Chinese Medicine Hospital) project, to realize the full range of cooperation from medical equipment, medical technology, drug supply and marketing.
8. Guizhou Sanli: a large pharmaceutical company engaged in the research and development, production and sales of modern Chinese medicine.
9. Medicine Stone Technology: the main business includes the research and development, design and sales of drug molecular masonry blocks.
10. Stalex: the company's controlling shareholder TaiGong Group Co., Ltd. holds a 30% stake in Shandong Xinhua Pharmaceutical Group Co.
11. Jianyou: the company owns high-value medicines such as heparin sodium enteric capsule, enoxaparin sodium injection, low-molecular-weight heparin calcium injection, naltrexate heparin calcium injection, and sulfated heparan decylate sodium injection, etc. The company is a leading supplier of heparin sodium enteric capsules, heparin sodium injection and other high-value medicines.
12. Qianyuan: a pharmaceutical holding group specializing in pharmaceuticals and pharmaceutical distribution.
13. Sinochem Iwacheng: dedicated to the research and development, production and sales of new non-metallic mineral materials, relying on the original advantages of the business covers the field of engineering services.
14. Fosun Pharma: The core business of Shanghai Fosun Pharma Co., Ltd. includes pharmaceuticals, medical devices and medical diagnostics, as well as healthcare services.
15.Jiuzhitang: Mainly engaged in the research, development, production and sales of donkey gum blood replenishing granules, six flavors of dihuang pills, suppositories and other series of products.
16.Dong'a Colla Corii Asini: the company is mainly engaged in the research and development, production and sales of Colla Corii Asini series products.
17.Qianjin Pharmaceutical: The company is a large-scale comprehensive pharmaceutical enterprise integrating R&D, production and sales of centralized western pharmaceuticals.
18. Enhua Pharmaceutical: the leading products include central nervous system drugs and cardiovascular drugs, of which anesthesia drugs occupy "half of the domestic market".
19. China Resources Sanjiu: domestic OTC drug leader, products include otc, prescription drugs, anesthesia drugs.
20.Lemay Pharmaceuticals: the company mainly does pharmaceutical research and development, production and sales, with a complete pharmaceutical industry chain.
21.Qianjin Pharmaceutical: the company is a large-scale comprehensive pharmaceutical enterprise integrating R&D, production and sales of centralized western pharmaceuticals.
22. Jiuzhitang: the company has its own production capacity of Chinese medicine granules and chemical preparations, and its core products, donkey gum blood granules and six flavors of di Huangwan, account for most of the company's revenue.
23. Dong'a Gum: The company is mainly engaged in the research and development, production and sales of Gum series products.
24. Zixin Pharmaceuticals: the main business is the research and development, production and sales of proprietary Chinese medicines.
25. Jiangzhong Pharmaceuticals: a Chinese medicine pharmaceutical enterprise with a history of nearly 50 years, with a large number of classic proprietary Chinese medicines, including Jiangzhong brand stomach-healthy elimination tablets, Jiangzhong compound grass coral tablets, Jiangzhong compound honeysuckle granules.
26. Antelope: Antelope has strong brand influence and competitiveness in the traditional Chinese medicine industry, and its main products include Shu Abdomen Paste Cream and Bone Musk Pain Relief Cream.
27. Enhua Pharmaceutical: the leading products include central nervous system drugs and cardiovascular drugs, of which anesthesia drugs occupy "half of the domestic market".
28. China Resources Shuanghe: focusing on the treatment of cardiovascular and cerebrovascular diseases, the development of a new class of national drugs "Terce" and the industrialization of technology projects with the international leading level.
29. Specialty Pharmaceuticals: Focusing on the production and sales of cough and phlegm medicines, the main products include cough medicine tablets, phenmetrazine tablets, and Jinlian heat-clearing effervescent tablets, etc.
30.
30.Great Wall Pharmaceuticals: the scope of business is the research and development, production and sales of drugs, there is no specific listed products.
Medical sector late-stage stock selection
Medical sector late-stage stock selection includes, but is not limited to, the following categories:
___Companies benefiting from the real demand for medical services. Companies in this category typically have a long chain of healthcare service delivery and are able to provide quality healthcare services.
___Companies related to the innovative drug industry chain.
___Companies related to medical informatization involving policy underpinnings.
___Companies with medical approval certificates.
__Companies with unique medical technologies.
__Hospitals in regional center cities.
The above is for reference only, investment is risky, decision-making should be cautious.
Medical Sector and Military Stocks
Medical sector and military stocks are both important sectors in China's stock market, and the following are some comparisons between medical sector and military stocks:
Medical sector:
___Medical sector is a collection of stocks in the pharmaceutical manufacturing, biomedical, and medical device industries.
__The medical sector is often considered a relatively sound investment sector because the medical industry is a long-term growth industry and is supported by government policies.
___Stock prices in the medical sector are usually affected by macroeconomic, policy and epidemic factors.
Military stocks:
__Military stocks are a collection of stocks involved in the defense industry.
__Military stocks are usually considered a relatively stable, high dividend paying, low risk sector because the military industry is a long term stable growth industry and the performance of military companies is less affected by macroeconomics and policies.
___The stock prices of military stocks are usually affected by macroeconomics, international situation, policies and other factors.
Overall, medical sector and military stocks are both relatively robust investment sectors, but they have different industry characteristics and influencing factors. Investors can choose the appropriate sectors and stocks according to their risk appetite and investment objectives.
That's all for the introduction of pharmaceutical stocks in the medical sector.